Closed · W81XWH-09-LCRP-CTRA · CFDA 12.420 · Discretionary
FY09 DOD Lung Cancer Research Program Collaborative Translational Research Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- December 3, 2009
- Close date
- 2
- Expected awards
The verdict
FY09 DOD Lung Cancer Research Program Collaborative Translational Research Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 2 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 2
- expected awards
- 12.420
- CFDA program
Archived opportunity record
FY09 DOD Lung Cancer Research Program Collabo… is closed (last close December 3, 2009). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed December 3, 2009
Est. Total Funding
$10,500,000
Expected Awards
2
Instrument
Grant
Description
The LCRP Collaborative Translational Research Award (CTRA) supports partnerships between clinicians and laboratory scientists at multiple institutions to conduct translational research in lung cancer.The purpose of the CTRA is to support multi-institutional, multi-disciplinary collaborations among clinicians and laboratory scientists that will accelerate the movement of promising ideas in lung cancer into clinical applications.The FY09 LCRP CTRA ONLY accepts applications that address at least two of the seven Areas of Emphasis listed below.• Identification or development of non-invasive or minimally invasive tools to improve the detection of the initial stages of lung cancer• Identification and development of tools for screening or early detection of lung cancer. Screening may include, but is not limited to, computed tomography scans, X-rays, other imaging, biomarkers, genetics/genomics/proteomics, and assessment of risk factors• Understanding the molecular mechanisms that lead to clinically significant lung cancer• Identification of the mechanisms that lead to the development of the various types of lung cancer• Identification of innovative strategies for prevention and treatment of early lung cancer• Understanding predictive and prognostic markers to identify responders and non-responders• Understanding acquired resistance to treatmentThe CTRA supports the development of translational research collaborations among four independent investigators (known as partners). The four partners, consisting of an Initiating Principal Investigator (PI) and three Partnering PIs, must be from at least two distinct institutions. The proposed research must address two or more of the seven Areas of Emphasis in a manner that would maximize the collective expertise of the investigators involved. At least one partner must be a clinician, and at least two partners must have experience either in lung cancer research or lung cancer patient care. It should be clear that all partners have equal intellectual input into the design of the research project. A proposed project in which one of the partners merely supplies tissue samples or access to patients will not meet the intent of this mechanism. See the Program Announcement for the full Funding Opportunity Description.
Catch-all / unrestricted eligibility mark · W81XWH-09-LCRP-CTRA
Grants.gov marks FY09 DOD Lung Cancer Research Program Collabo… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
FY09 DOD Lung Cancer Research Program Collabo… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |